Rab11a Differentially Modulates Epidermal Growth Factor-induced Proliferation and Motility in Immortal Breast Cells Diane PalmieriAmina BouadisPatricia S. Steeg Preclinical Study 22 June 2006 Pages: 127 - 137
E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis Bonnie E. Gould RothbergMichael B. Bracken Pre-clinical study 22 June 2006 Pages: 139 - 148
Advanced breast cancer: anti-progressive immunotherapy using a thermostable autologous hemoderivative Eduardo Lasalvia-PriscoJesús VázquezEduardo Lasalvia-Galante Clinical Trial 04 July 2006 Pages: 149 - 160
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival L. KostadimaG. PentheroudakisG. Hennig Clinical Trial 18 July 2006 Pages: 161 - 167
Association of GSTP1 CpG Islands Hypermethylation with Poor Prognosis in Human Breast Cancers Takashi AraiYasuo MiyoshiShinzaburo Noguchi Clinical Trial 22 June 2006 Pages: 169 - 176
Plasma Levels of Tamoxifen, N-Desmethyl Tamoxifen and Anastrozole in a Patient with Metastatic Breast Cancer and Chronic Hemodialysis T. LangeneggerP. WahlB. Thürlimann Clinical Trial 11 May 2006 Pages: 177 - 181
Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer Julie LemieuxAdam ToppPamela J. Goodwin Clinical trial 14 June 2006 Pages: 183 - 190
Psychological Distress in U.S. Women Who Have Experienced False-Positive Mammograms Ismail JatoiKangmin ZhuWilliam Lawrence Epidemiology 14 June 2006 Pages: 191 - 200
Infertility, Ovulation Induction Treatments and the Incidence of Breast Cancer—a Historical Prospective Cohort of Israeli Women L. Lerner-GevaL. Keinan-BokerB. Lunenfeld Epidemiology 10 May 2006 Pages: 201 - 212
Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer Ji-Yeob ChoiKyoung-Mu LeeDaehee Kang Epidemiology 04 July 2006 Pages: 213 - 218
Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study Catherine BuettnerCandyce H. KroenkeMichelle D. Holmes OriginalPaper 05 July 2006 Pages: 219 - 227
REporting recommendations for tumor MARKer prognostic studies (REMARK) Lisa M. McShaneDouglas G. AltmanGary M. Clark Letter to the Editor 24 August 2006 Pages: 229 - 235
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK Daniel F. HayesStephen EthierMarc E. Lippman Letter to the Editor 14 June 2006 Pages: 237 - 238